ARTICLE | Financial News
Celgene up on Thalomid approval
May 27, 2006 12:06 AM UTC
On Friday, CELG gained $1.02 to $41.46 after announcing late Thursday that FDA approved an sNDA for Thalomid thalidomide for use in combination with dexamethasone to treat newly diagnosed multiple mye...